Finance

BioNTech transitions focus from COVID-19 vaccines to cancer therapies, particularly mRNA-based treatments. Despite declining profits—from 1.90 euros to 1.08 euros per share—BioNTech exceeded earning forecasts, boosting optimism. Annual performance shows…

Quantum computing is poised to revolutionize financial markets, creating a new investment category known as "quantum stocks." Quantum computers, using qubits, promise unparalleled efficiency in solving complex problems, impacting industries…